Thyroid cancer risk 40 + years after irradiation for an enlarged thymus: An update of the Hempelmann cohort

Jacob Adams, Roy E. Shore, Ann Dozier, Steven E Lipshultz, Ronald G. Schwartz, Louis S. Constine, Thomas A. Pearson, Marilyn Stovall, Kelly Thevenet-Morrison, Susan G. Fisher

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Although ionizing radiation is a known carcinogen, the long-term risk from relatively higher-dose diagnostic procedures during childhood is less well known. We evaluated this risk indirectly by assessing thyroid cancer incidence in a cohort treated with "lower-dose" chest radiotherapy more than 55 years ago. Between 2004 and 2008, we re-surveyed a population-based cohort of subjects treated with radiation for an enlarged thymus during infancy between 1926 and 1957 and their unexposed siblings. Thyroid cancer occurred in 50 irradiated subjects (mean thyroid dose, 1.29 Gy) and in 13 nonirradiated siblings during 334,347 person-years of follow-up. After adjusting for attained age, Jewish religion, sex and history of goiter, the rate ratio for thyroid cancer was 5.6 (95% CI: 3.110.8). The adjusted excess relative risk per gray was 3.2 (95% CI: 1.56.6). The adjusted excess absolute risk per gray was 2.2 cases (95% CI: 1.43.2) per 10,000 person-years. Cumulative thyroid cancer incidence remains elevated in this cohort after a median 57.5 years of follow-up and is dose-dependent. Although the incidence appeared to decrease after 40 years, increased risk remains a lifelong concern in those exposed to lower doses of medical radiation during early childhood.

Original languageEnglish
Pages (from-to)753-762
Number of pages10
JournalRadiation Research
Volume174
Issue number6 A
DOIs
StatePublished - Dec 16 2010

Fingerprint

Thyroid Neoplasms
Thymus Gland
cancer
dosage
irradiation
incidence
Religion and Sex
Incidence
Radiation
carcinogens
chest
Goiter
radiation
Ionizing Radiation
ionizing radiation
Carcinogens
radiation therapy
Thyroid Gland
Radiotherapy
Thorax

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Biophysics
  • Radiation

Cite this

Adams, J., Shore, R. E., Dozier, A., Lipshultz, S. E., Schwartz, R. G., Constine, L. S., ... Fisher, S. G. (2010). Thyroid cancer risk 40 + years after irradiation for an enlarged thymus: An update of the Hempelmann cohort. Radiation Research, 174(6 A), 753-762. https://doi.org/10.1667/RR2181.1

Thyroid cancer risk 40 + years after irradiation for an enlarged thymus : An update of the Hempelmann cohort. / Adams, Jacob; Shore, Roy E.; Dozier, Ann; Lipshultz, Steven E; Schwartz, Ronald G.; Constine, Louis S.; Pearson, Thomas A.; Stovall, Marilyn; Thevenet-Morrison, Kelly; Fisher, Susan G.

In: Radiation Research, Vol. 174, No. 6 A, 16.12.2010, p. 753-762.

Research output: Contribution to journalArticle

Adams, J, Shore, RE, Dozier, A, Lipshultz, SE, Schwartz, RG, Constine, LS, Pearson, TA, Stovall, M, Thevenet-Morrison, K & Fisher, SG 2010, 'Thyroid cancer risk 40 + years after irradiation for an enlarged thymus: An update of the Hempelmann cohort', Radiation Research, vol. 174, no. 6 A, pp. 753-762. https://doi.org/10.1667/RR2181.1
Adams J, Shore RE, Dozier A, Lipshultz SE, Schwartz RG, Constine LS et al. Thyroid cancer risk 40 + years after irradiation for an enlarged thymus: An update of the Hempelmann cohort. Radiation Research. 2010 Dec 16;174(6 A):753-762. https://doi.org/10.1667/RR2181.1
Adams, Jacob ; Shore, Roy E. ; Dozier, Ann ; Lipshultz, Steven E ; Schwartz, Ronald G. ; Constine, Louis S. ; Pearson, Thomas A. ; Stovall, Marilyn ; Thevenet-Morrison, Kelly ; Fisher, Susan G. / Thyroid cancer risk 40 + years after irradiation for an enlarged thymus : An update of the Hempelmann cohort. In: Radiation Research. 2010 ; Vol. 174, No. 6 A. pp. 753-762.
@article{98ab718907e14d0b81532857935910a9,
title = "Thyroid cancer risk 40 + years after irradiation for an enlarged thymus: An update of the Hempelmann cohort",
abstract = "Although ionizing radiation is a known carcinogen, the long-term risk from relatively higher-dose diagnostic procedures during childhood is less well known. We evaluated this risk indirectly by assessing thyroid cancer incidence in a cohort treated with {"}lower-dose{"} chest radiotherapy more than 55 years ago. Between 2004 and 2008, we re-surveyed a population-based cohort of subjects treated with radiation for an enlarged thymus during infancy between 1926 and 1957 and their unexposed siblings. Thyroid cancer occurred in 50 irradiated subjects (mean thyroid dose, 1.29 Gy) and in 13 nonirradiated siblings during 334,347 person-years of follow-up. After adjusting for attained age, Jewish religion, sex and history of goiter, the rate ratio for thyroid cancer was 5.6 (95{\%} CI: 3.110.8). The adjusted excess relative risk per gray was 3.2 (95{\%} CI: 1.56.6). The adjusted excess absolute risk per gray was 2.2 cases (95{\%} CI: 1.43.2) per 10,000 person-years. Cumulative thyroid cancer incidence remains elevated in this cohort after a median 57.5 years of follow-up and is dose-dependent. Although the incidence appeared to decrease after 40 years, increased risk remains a lifelong concern in those exposed to lower doses of medical radiation during early childhood.",
author = "Jacob Adams and Shore, {Roy E.} and Ann Dozier and Lipshultz, {Steven E} and Schwartz, {Ronald G.} and Constine, {Louis S.} and Pearson, {Thomas A.} and Marilyn Stovall and Kelly Thevenet-Morrison and Fisher, {Susan G.}",
year = "2010",
month = "12",
day = "16",
doi = "10.1667/RR2181.1",
language = "English",
volume = "174",
pages = "753--762",
journal = "Radiation Research",
issn = "0033-7587",
publisher = "Radiation Research Society",
number = "6 A",

}

TY - JOUR

T1 - Thyroid cancer risk 40 + years after irradiation for an enlarged thymus

T2 - An update of the Hempelmann cohort

AU - Adams, Jacob

AU - Shore, Roy E.

AU - Dozier, Ann

AU - Lipshultz, Steven E

AU - Schwartz, Ronald G.

AU - Constine, Louis S.

AU - Pearson, Thomas A.

AU - Stovall, Marilyn

AU - Thevenet-Morrison, Kelly

AU - Fisher, Susan G.

PY - 2010/12/16

Y1 - 2010/12/16

N2 - Although ionizing radiation is a known carcinogen, the long-term risk from relatively higher-dose diagnostic procedures during childhood is less well known. We evaluated this risk indirectly by assessing thyroid cancer incidence in a cohort treated with "lower-dose" chest radiotherapy more than 55 years ago. Between 2004 and 2008, we re-surveyed a population-based cohort of subjects treated with radiation for an enlarged thymus during infancy between 1926 and 1957 and their unexposed siblings. Thyroid cancer occurred in 50 irradiated subjects (mean thyroid dose, 1.29 Gy) and in 13 nonirradiated siblings during 334,347 person-years of follow-up. After adjusting for attained age, Jewish religion, sex and history of goiter, the rate ratio for thyroid cancer was 5.6 (95% CI: 3.110.8). The adjusted excess relative risk per gray was 3.2 (95% CI: 1.56.6). The adjusted excess absolute risk per gray was 2.2 cases (95% CI: 1.43.2) per 10,000 person-years. Cumulative thyroid cancer incidence remains elevated in this cohort after a median 57.5 years of follow-up and is dose-dependent. Although the incidence appeared to decrease after 40 years, increased risk remains a lifelong concern in those exposed to lower doses of medical radiation during early childhood.

AB - Although ionizing radiation is a known carcinogen, the long-term risk from relatively higher-dose diagnostic procedures during childhood is less well known. We evaluated this risk indirectly by assessing thyroid cancer incidence in a cohort treated with "lower-dose" chest radiotherapy more than 55 years ago. Between 2004 and 2008, we re-surveyed a population-based cohort of subjects treated with radiation for an enlarged thymus during infancy between 1926 and 1957 and their unexposed siblings. Thyroid cancer occurred in 50 irradiated subjects (mean thyroid dose, 1.29 Gy) and in 13 nonirradiated siblings during 334,347 person-years of follow-up. After adjusting for attained age, Jewish religion, sex and history of goiter, the rate ratio for thyroid cancer was 5.6 (95% CI: 3.110.8). The adjusted excess relative risk per gray was 3.2 (95% CI: 1.56.6). The adjusted excess absolute risk per gray was 2.2 cases (95% CI: 1.43.2) per 10,000 person-years. Cumulative thyroid cancer incidence remains elevated in this cohort after a median 57.5 years of follow-up and is dose-dependent. Although the incidence appeared to decrease after 40 years, increased risk remains a lifelong concern in those exposed to lower doses of medical radiation during early childhood.

UR - http://www.scopus.com/inward/record.url?scp=78649999084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649999084&partnerID=8YFLogxK

U2 - 10.1667/RR2181.1

DO - 10.1667/RR2181.1

M3 - Article

C2 - 21128799

AN - SCOPUS:78649999084

VL - 174

SP - 753

EP - 762

JO - Radiation Research

JF - Radiation Research

SN - 0033-7587

IS - 6 A

ER -